Body Composition and Progression of Biopsy‐Proven Non‐Alcoholic Fatty Liver Disease in Patients With Obesity
Authors:
Open Access
- 10 October 2024
- journal article
- research article
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 15 (6) , 2608-2617
Abstract
Background: Obesity is a significant risk factor for the progression of non‐alcoholic fatty liver disease (NAFLD). However, a convenient and efficacious non‐invasive test for monitoring NAFLD progression in patients with obesity is currently lacking. This study aims to investigate the associations between CT‐based body composition and the progression of biopsy‐proven NAFLD in patients with obesity.Methods: Liver biopsy was conducted in patients with obesity, and the progression of NAFLD was evaluated by the NAFLD activity score (NAS). Body composition was assessed through abdominal computed tomography (CT) scans.Results: A total of 602 patients with an average age of 31.65 (±9.33) years old were included, comprising 217 male patients and 385 female patients. The wall skeletal muscle index (SMI), total SMI, and visceral fat index (VFI) were positively correlated with NAS in both male and female patients. Multivariate regression analysis demonstrated significant associations between high liver steatosis and wall SMI (HR: 1.60, 95% CI: 1.12 to 2.30), total SMI (HR: 1.50, 95% CI: 1.02 to 2.08), VSI (HR: 2.16, 95% CI: 1.48 to 3.14), visceral fat to muscle ratio (HR: 1.51, 95% CI: 1.05 to 2.18), and visceral to subcutaneous fat ratio (HR: 1.51, 95% CI: 1.07 to 2.12). Non‐alcoholic steatohepatitis (NASH) was significantly associated with wall SMI (HR: 1.52, 95% CI: 1.06 to 2.19) and VSI (HR: 1.50, 95% CI: 1.03 to 2.17). Liver fibrosis ≥ F2 was significantly associated with psoas muscle index (HR: 0.64, 95% CI: 0.44 to 0.93) and psoas skeletal muscle density (HR: 0.61, 95% CI: 0.41 to 0.89).Conclusions: Our study suggested that certain CT‐based body composition indicators, notably high VFI, were significantly associated with the progression of NAFLD in patients with obesity. Great attentions and timely managements should be given to these patients with body composition characteristics associated with the risk of NAFLD progression.Keywords
Funding Information
- China Postdoctoral Science Foundation (2023TQ0225)
- Natural Science Foundation of Sichuan Province (24NSFSC6777)
- National Natural Science Foundation of China (92157109)
This publication has 39 references indexed in Scilit:
- Body Composition in Advanced Non-Small Cell Lung Cancer Treated With ImmunotherapyJAMA Oncology, 2024
- Influence of skeletal muscle and intermuscular fat on postoperative complications and long‐term survival in rectal cancer patientsJournal of Cachexia, Sarcopenia and Muscle, 2024
- Obesity paradox in patients with non‐small cell lung cancer undergoing immune checkpoint inhibitor therapyJournal of Cachexia, Sarcopenia and Muscle, 2023
- Muscle Fat Content Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis in Chinese AdultsThe Journal of nutrition, health and aging, 2023
- Muscle fat contents rather than muscle mass determines nonalcoholic steatohepatitis and liver fibrosis in patients with severe obesityObesity, 2022
- The relationship between the mode of presentation, CT‐derived body composition, systemic inflammatory grade and survival in colon cancerJournal of Cachexia, Sarcopenia and Muscle, 2022
- Low skeletal muscle mass is associated with more severe histological features of non-alcoholic fatty liver disease in maleHepatology International, 2022
- Muscle Area and Density Assessed by Abdominal Computed Tomography in Healthy Adults: Effect of Normal Aging and Derivation of Reference ValuesThe Journal of nutrition, health and aging, 2022
- Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysisHepatology International, 2019
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005